Auer rod-like inclusions in a low-grade B-cell leukemia

Annals of Diagnostic Pathology
Alexandra C HristovChristopher D Gocke

Abstract

Auer rods define neoplastic blasts of myeloid origin. However, azurophilic, needle-shaped, Auer rod-like inclusions have rarely been reported in the neoplastic cells of patients with B-cell malignancies, including chronic lymphocytic leukemia/small lymphocytic lymphoma. Here, we report a case of low-grade B-cell leukemia most consistent with chronic lymphocytic leukemia/small lymphocytic lymphoma that displayed numerous intracytoplasmic, needle-shaped, azurophilic rods resembling Auer rods. Furthermore, we review the literature on Auer rod-like structures in B-cell neoplasms.

References

Jul 1, 1991·American Journal of Clinical Pathology·D A GroomL K Macaulay
Jan 1, 1987·Acta Haematologica·H S JunejaD F Bainton
Jan 1, 1982·Virchows Archiv. A, Pathological Anatomy and Histology·E RalfkiaerM M Hansen
Feb 1, 1980·American Journal of Clinical Pathology·C R KjeldsbergH Rappaport
Feb 1, 1994·Human Pathology·C H DunphyF R Dunphy
Feb 8, 2003·Annals of Hematology·G MetzgerothJ Hastka
Apr 30, 2005·Archives of Pathology & Laboratory Medicine·Mahesha VVinay Sakhuja
Oct 25, 2008·Leukemia Research·Yataro YoshidaHitotshi Ohno
Feb 20, 2009·International Journal of Hematology·Toru TakahashiKatsuhiro Hatao

❮ Previous
Next ❯

Citations

Oct 9, 2014·International Journal of Hematology·Sonoko Nakano-AkamatsuTohru Inaba
Mar 18, 2016·International Journal of Hematology·Toshiki YamadaHisashi Tsurumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Apostolia-Maria TsimberidouMichael J Keating
© 2021 Meta ULC. All rights reserved